home / stock / avcnf / avcnf news

AVCNF News and Press, Avicanna Inc

Stock Information
Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com
Menu
AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...
AVCNF - Avicanna Announces Medical Cannabis Real World Evidence Results and Publication

TORONTO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, today...
AVCNF - Avicanna Announces Changes to its Board of Directors

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, annou...

AVCNF - Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update

Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “...

AVCNF - Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress Transcript

2025-12-17 13:59:05 ET Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress December 17, 2025 10:00 AM EST... Read the full article on Seeking Alpha For further details see: Avicanna Inc. (AVCN:CA) Discusses Strategic Pivo...
AVCNF - Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform

PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery platform which can be loaded into products such as tablets, capsules, sachets and pouches ...

AVCNF - Avicanna Reports Q3 2025

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products...

AVCNF - Avicanna Announces Change in CFO

TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based pro...
AVCNF - Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland

This marks the first export of organic certified flower for SMGH, 20 th international market for Aureus branded products and 23 rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company )...

AVCNF - Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States

re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United States includes two products available at Harrington Wellness’ replaycbd.com as ...

AVCNF - Avicanna reports Q2 results

2025-08-14 12:05:28 ET More on Avicanna Financial information for Avicanna Inc. Read the full article on Seeking Alpha For further details see: Avicanna reports Q2 results
Next 10